If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Chadds Ford families about 20 minutes north via Route 202, with both MiSight contact lenses, which are FDA-approved to slow myopia progression, and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, so if anything beyond myopia ever comes up, expert care is already in place.
Chadds Ford sits in the heart of the Brandywine Valley, Wyeth country, where Route 1 winds past the Brandywine River Museum and rolling farmland straddling the Delaware County and Chester County line. Families from the township, Fairville, Hamorton, and the surrounding valley make the drive of about 20 minutes north to our West Chester office, frequently after realizing a child's prescription has crept stronger at each annual exam. That gradual climb is exactly what a myopia control plan is designed to slow.
Myopia control is not a one-time purchase; it is a multi-year plan we measure, adjust, and monitor as your child grows. Between device-heavy classrooms, long reading assignments, and less time outdoors than earlier generations logged, more Chadds Ford children are becoming nearsighted at younger ages than their parents did. Because Mudgil Eye Associates is a full MD-and-OD practice, a residency-trained pediatric optometrist and a Johns Hopkins fellowship-trained pediatric ophthalmologist work side by side, so anything your child's eyes might need is already covered.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, a pediatric ophthalmologist's expertise is already part of their care.
Nearsightedness can seem like nothing more than needing glasses for the whiteboard, but the change underneath is physical. In a myopic eye, the eyeball has grown a touch too long from front to back, an effect specialists call axial elongation. With the eye overlong, light from distant objects focuses a little in front of the retina rather than on it, so far-off things blur while near things stay sharp. Glasses and standard contacts bend that light to restore focus, but they do nothing about the eye's length or the speed of its growth. Reining in that growth is what myopia control is for.
The point is far bigger than a thinner lens at the next appointment. Every additional degree of nearsightedness means a longer, more stretched eye and a greater lifetime chance of problems such as retinal detachment, glaucoma, earlier cataract, and myopic maculopathy down the road. By slowing how quickly the myopia advances while a child is still growing, we aim to leave them with a lower adult prescription, and a lower prescription carries lower long-term risk. To be clear, myopia control does not cure or reverse nearsightedness that is already present, and results vary from child to child, but for most children it slows the pace in a meaningful way.
Childhood myopia is increasing across the country, and the Brandywine Valley is no exception. Genetics carry real weight, so a child with one or two nearsighted parents begins with higher odds, yet daily life adds to it. Extended near focus for homework, reading, and screens, together with fewer hours outdoors in natural light, is tied to faster progression. For a Chadds Ford family, one of the simplest evidence-supported steps is guarding steady outdoor time, which is why we fold daily habits into the plan rather than treating them as an afterthought.
For a Chadds Ford child who is old enough and ready to wear a contact lens, MiSight 1 day is often where we begin. It is the only soft contact lens the FDA has approved specifically to slow the progression of myopia in children, and because it is a daily-disposable lens worn through the day, it also corrects distance vision while it is worn. Many families find that convenient at school and on the trail, and results vary from child to child.
A MiSight lens feels just like a regular soft contact, but it is engineered with concentric treatment zones. The center corrects distance vision clearly, while the surrounding rings focus part of the light slightly ahead of the peripheral retina, a cue that appears to temper the eye's push to keep lengthening. In the manufacturer's multi-year clinical study, children wearing MiSight progressed, on average, considerably more slowly than a control group, roughly a 59 percent reduction in the rate of progression over three years. That number is a clinical-study finding, and the benefit any individual child sees varies.
MiSight generally fits school-age and older children, often beginning around ages 8 to 12, who are responsible enough to insert, remove, and care for a lens with a parent's help at first. Because a fresh lens is used daily and thrown away at night, there is no cleaning solution or storage case to manage. Significant astigmatism can make a child a less-than-ideal candidate, one of the details Dr. Julakanti checks at the fitting. For the lenses to work, they need to be worn most waking hours, generally at least ten hours a day, six or more days a week, until the eyes stop growing and the prescription settles.
Not every Chadds Ford child is ready to handle a contact lens, and for those families a single bedtime drop is an appealing alternative. Low-dose atropine has become one of the most widely discussed approaches to slowing childhood myopia, and for the right child it is simple and well tolerated. Because it asks so little of the child, it is frequently where we start with younger patients.
Atropine is a long-established eye medication. In the very low concentrations used for myopia control, usually 0.01% to 0.05%, it is prescribed off-label to slow the eye's elongation over time. That is a different purpose, and a much weaker strength, than the dilating drops used at a comprehensive eye exam, which is why the side effects people tend to associate with atropine are usually minimal at these doses.
The appeal is how easy it is. One drop goes into each eye at bedtime, tucked into the evening routine, and the child wears their usual glasses during the day. There is nothing to insert, clean, or store. Because the dose is so small, many children feel no difference at all, while a few notice slight light sensitivity or a minor change in close focus, which we watch for and can ease by adjusting the concentration.
Part of what makes atropine work well as a managed treatment is that its strength can be fine-tuned. We often start at a lower concentration and adjust based on how the prescription responds over the months that follow. It is not a prescribe-and-forget drop; it is a plan our optometric team revisits at every follow-up, tracking both the pace of progression and how comfortably your child tolerates the drop.
The best time to begin myopia control is early in the progression, while the eye is still growing and there is more future change left to prevent. In practice, that is often the first time a child needs distance glasses, or the first time a prescription jumps between annual exams. Myopia most commonly appears between about ages 8 and 12, though it can start earlier, and a Chadds Ford child with nearsighted parents or a fast-changing prescription deserves a closer look sooner rather than later. No referral is needed to schedule an evaluation.
Most nearsighted children are candidates for some form of myopia control. The clearest signs that it is time to ask us include a prescription that climbs at every visit, squinting or sitting close to the board or television, frequent headaches or eye strain, or a family history of high myopia. The only way to know which option fits is a comprehensive evaluation, and part of our job is to tell you plainly whether myopia control is likely to help your child and which approach makes the most sense.
A myopia control evaluation is a thorough pediatric eye exam, not a quick screening. We measure your child's vision and full prescription, often using dilating drops for accuracy, check eye alignment and overall eye health, and take baseline measurements so we can track progression precisely over time. Then we sit down with you and your child, explain the findings in plain language, and lay out the options, including what each treatment involves day to day, what it can and cannot do, and the follow-up schedule. If a contact lens is the plan, we fit it and teach your child to handle it. Expect the visit to take a little longer than a comprehensive eye exam, especially if drops are used.
Parents in Chadds Ford often arrive having read about several myopia treatments and wondering which single one is best. The more useful question is usually which combination and sequence fits their particular child, because myopia control is rarely a one-method decision. We tailor the plan to the individual, and sometimes that means using more than one approach. The West Chester office is a short drive away, and personalized planning is at the heart of how we work.
Two children with the same prescription can need very different plans. Age, maturity and readiness to handle lenses, how fast the myopia is progressing, daily routine, sports, and family preferences all shape the right choice. A method that suits a contact-lens-ready twelve-year-old may not fit a younger child, and a fast-progressing eye may call for a more assertive approach than a slowly changing one. Personalization starts with understanding the whole picture, not just the number on the prescription.
We work from a set of evidence-based tools. MiSight 1 day soft contact lenses are FDA-approved to slow progression in children around ages 8 to 12. Low-dose atropine drops, commonly 0.01% to 0.05%, are used off-label at bedtime. Each has its strengths, and each suits certain children better than others. The art of a personalized plan is matching the right building block, or blocks, to the child in front of us.
In some cases, a single method does not slow progression as much as we would like, and combining approaches can be considered. For example, a child using a contact-lens method might also use low-dose atropine drops as part of a layered plan. Any combination is something we weigh carefully, monitor closely, and adjust over time. It is never a guess; it is a managed strategy that the team revisits at each follow-up based on how the eyes are responding.
Personalization does not end at the first decision. As a child grows, becomes more capable with lenses, or shows a different rate of progression, the plan can shift. We might step a treatment up, change a concentration, or move from one method to another. Dr. Mudgil, a board-certified ophthalmologist with Johns Hopkins/Wilmer fellowship training, and our optometrist keep the plan aligned with the child's current needs. The constant goal is slowing progression, because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child has an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program for Chadds Ford families, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and following each child's progress across the years of treatment. Optometrists are the cornerstone of children's vision care, and Dr. Julakanti's focused pediatric training is exactly what a growing, changing prescription calls for.
Working with her is Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Brandywine Valley and Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having both an optometrist and a fellowship-trained pediatric ophthalmologist in one practice means that if your child ever needs more than myopia control, from a difficult prescription to eye misalignment or a medical concern, that expertise is already part of the care team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the Chadds Ford area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. Chadds Ford-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control works best when it begins early, while the eye is still growing and the most future change can still be prevented. Many Chadds Ford children start between about ages 6 and 12, often at the first sign a prescription is climbing, though there is no single perfect age. Because the goal is to limit future change, an earlier start usually means a lower final prescription. If your child is newly nearsighted or the numbers keep rising, an evaluation now is better than waiting.
No. Myopia control does not cure nearsightedness or reverse the prescription your child already has. Its purpose is to slow how fast the myopia progresses during the growing years, so your child ends up less nearsighted than they otherwise would. Your child will still wear glasses or contacts to see clearly, and results vary from child to child.
Neither is better for every child; the right fit depends on yours. MiSight 1 day lenses suit an older, contact-lens-ready child who is comfortable wearing a lens during the day. Low-dose atropine, a simple nightly drop with glasses worn by day, suits younger children or those not ready for contacts. Both are evidence-based and proven to slow progression, and Dr. Julakanti helps you choose based on age, prescription, comfort with lenses, and lifestyle.
In some cases, yes. When a single method does not slow progression as much as we would like, a child on a contact-lens method may also use low-dose atropine as part of a layered plan. Any combination is weighed carefully, monitored closely, and adjusted over time; it is a managed strategy we revisit at each follow-up, not a default starting point.
For most children it meaningfully slows the rate of progression, though it does not stop it entirely or reverse existing nearsightedness. In its multi-year clinical study, MiSight was associated with roughly a 59 percent reduction in the rate of progression over three years, and low-dose atropine has slowed progression across multiple studies. These are clinical-study findings; how much any individual child benefits varies, which is why we monitor and adjust at regular visits.
Yes. Myopia control tends to suit active Chadds Ford kids well. MiSight 1 day lenses are worn during the day and correct distance vision while they are worn, which many children prefer for sports, and each lens is discarded at night. Low-dose atropine is a bedtime drop, so it never interferes with daytime activity; the child simply wears their regular glasses or sports eyewear. We are glad to talk through protective eyewear for your child's sport. Results vary from child to child.
Low-dose atropine is used off-label for myopia control; the low concentrations involved, commonly 0.01% to 0.05%, have a long track record in eye care and are generally very well tolerated. MiSight, by contrast, is FDA-approved specifically to slow myopia progression in children. Most children on atropine have no side effects, while a few notice mild light sensitivity or a slight effect on near focus, which we can manage by adjusting the concentration.
You do not need a referral to schedule a myopia evaluation. Coverage for myopia control varies by plan, and some services or materials may not be covered by medical insurance, so our team reviews the details with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will help you understand the options.
Most Chadds Ford families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.